D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 20,085 338 World Ranking 9990 National Ranking 137

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His primary areas of study are Cancer research, Internal medicine, Immunology, Molecular biology and DNA methylation. His Cancer research research integrates issues from Downregulation and upregulation, Kinase activity, microRNA, Lymphoma and Tumor suppressor gene. The concepts of his Internal medicine study are interwoven with issues in Surgery, Oncology and Cardiology.

The Surgery study combines topics in areas such as Adverse effect, Clinical trial and Multiple myeloma. His Immunology study combines topics from a wide range of disciplines, such as Progenitor cell, Stem cell and Ischemia. Felipe Prosper interconnects Methylation, Epigenetics and B cell in the investigation of issues within DNA methylation.

His most cited work include:

  • Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. (871 citations)
  • Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation (401 citations)
  • Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study (356 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Cancer research, Internal medicine, Multiple myeloma, Cell biology and Stem cell. His Cancer research research is multidisciplinary, incorporating perspectives in Cancer, Epigenetics, Immunology and DNA methylation. His study in DNA methylation is interdisciplinary in nature, drawing from both Molecular biology, Methylation and B cell.

His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery, Oncology and Cardiology. His Multiple myeloma research incorporates elements of Bone marrow and Circulating tumor cell. The study incorporates disciplines such as Bioinformatics and Adult stem cell in addition to Stem cell.

He most often published in these fields:

  • Cancer research (28.24%)
  • Internal medicine (20.61%)
  • Multiple myeloma (14.69%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (28.24%)
  • Multiple myeloma (14.69%)
  • Internal medicine (20.61%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Cancer research, Multiple myeloma, Internal medicine, Epigenetics and Cell biology. His Cancer research research is multidisciplinary, incorporating elements of Cell, Haematopoiesis, Cell growth, B cell and Immunotherapy. The various areas that Felipe Prosper examines in his Multiple myeloma study include Circulating tumor cell, Transcriptome, Computational biology, Bone marrow and Transplantation.

His work on Internal medicine is being expanded to include thematically relevant topics such as Oncology. Felipe Prosper interconnects Regulation of gene expression, Histone, DNA and DNA methylation in the investigation of issues within Epigenetics. His Cell biology research incorporates themes from Enhancer, Gene expression, Phenotype, Chromatin and Fibrosis.

Between 2018 and 2021, his most popular works were:

  • Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. (871 citations)
  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (106 citations)
  • The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma. (63 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

His primary areas of investigation include Cancer research, Cell biology, Bone marrow, Multiple myeloma and Epigenetics. His biological study focuses on Myeloid leukemia. His Cell biology research is multidisciplinary, incorporating elements of Plasma cell, Gene expression, Phenotype, Chromatin and Fibrosis.

The subject of his Multiple myeloma research is within the realm of Internal medicine. Felipe Prosper has researched Internal medicine in several fields, including Differential diagnosis, Immunophenotyping and AL amyloidosis. His studies in Epigenetics integrate themes in fields like DNA methylation, Hepatic stellate cell, Histone, Enhancer and Regulation of gene expression.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.

Vanessa Monteil;Hyesoo Kwon;Patricia Prado;Astrid Hagelkrüys.
Cell (2020)

1011 Citations

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

María-Victoria Mateos;María-Victoria Mateos;José-M. Hernández;José-M. Hernández;Miguel-T. Hernández;Miguel-T. Hernández;Norma-C. Gutiérrez;Norma-C. Gutiérrez.
Blood (2006)

523 Citations

Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation

Olga Gutierrez;Carlos Pipaon;Naohiro Inohara;Ana Fontalba.
Journal of Biological Chemistry (2002)

522 Citations

Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL

Machiko Horita;Enrique Jose Andreu;Adalberto Benito;Cristina Arbona.
Journal of Experimental Medicine (2000)

512 Citations

Epigenetic regulation of microRNA expression in colorectal cancer

Eva Bandres;Xabier Agirre;Nerea Bitarte;Natalia Ramirez.
International Journal of Cancer (2009)

499 Citations

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

María-Victoria Mateos;Miguel-Teodoro Hernández;Pilar Giraldo;Javier de la Rubia.
The New England Journal of Medicine (2013)

463 Citations

Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction.

Jesús Herreros;Felipe Prósper;Ana Perez;Juan J Gavira.
European Heart Journal (2003)

453 Citations

Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.

Maite Silva;Adalberto Benito;Cristina Sanz;Felipe Prosper.
Journal of Biological Chemistry (1999)

395 Citations

A DNA methylation fingerprint of 1628 human samples

Augustin F. Fernandez;Yassen Assenov;Jose Ignacio Martin-Subero;Balazs Balint.
Genome Research (2012)

357 Citations

Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.

Xabier Agirre;Amaia Vilas-Zornoza;Antonio Jiménez-Velasco;José Ignacio Martin-Subero.
Cancer Research (2009)

307 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Felipe Prosper

Catherine M. Verfaillie

Catherine M. Verfaillie

KU Leuven

Publications: 95

Manel Esteller

Manel Esteller

Institució Catalana de Recerca i Estudis Avançats

Publications: 73

Reiner Siebert

Reiner Siebert

University of Ulm

Publications: 54

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 51

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 51

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 49

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 48

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 46

Philippe Menasché

Philippe Menasché

Université Paris Cité

Publications: 45

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 44

Jesús F. San Miguel

Jesús F. San Miguel

University of Navarra

Publications: 40

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 39

Ola Landgren

Ola Landgren

University of Miami

Publications: 39

Elias Campo

Elias Campo

University of Barcelona

Publications: 37

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 36

Andreas Strasser

Andreas Strasser

Walter and Eliza Hall Institute of Medical Research

Publications: 33

Trending Scientists

David W. Jacobs

David W. Jacobs

University of Maryland, College Park

Leonhard Reindl

Leonhard Reindl

University of Freiburg

Mohamed Darouach

Mohamed Darouach

University of Lorraine

Brian A. Wandell

Brian A. Wandell

Stanford University

Hyun Jin Park

Hyun Jin Park

Korea University

Peter L. Steponkus

Peter L. Steponkus

Cornell University

Carmela R. Abraham

Carmela R. Abraham

Boston University

Michael Hess

Michael Hess

University of Veterinary Medicine Vienna

Brian R. Murphy

Brian R. Murphy

Murphy Oil Corporation (United States)

Mark W. Greenlee

Mark W. Greenlee

University of Regensburg

Albert F.G. Leentjens

Albert F.G. Leentjens

Maastricht University

Helene H. Fung

Helene H. Fung

Chinese University of Hong Kong

Umberto Vitolo

Umberto Vitolo

University of Turin

Ian E. Krop

Ian E. Krop

Harvard University

Wolfgang Wessels

Wolfgang Wessels

University of Cologne

Mark Hannam

Mark Hannam

Cardiff University

Something went wrong. Please try again later.